{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/695ead68a32e86d775858194/695eada9313b808065d2cc8f?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Drug that Debunks Free Will","description":"<p>This week, former Slate Money host <a href=\"https://twitter.com/mathbabedotorg?lang=en\">Cathy O’Neill</a> joins <a href=\"https://twitter.com/felixsalmon\">Felix Salmon</a>, <a href=\"https://twitter.com/EmilyRPeck?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Emily Peck</a>, and <a href=\"https://twitter.com/espiers\">Elizabeth Spiers</a> to discuss the technical glitch at the New York Stock Exchange. They also talk about a new <a href=\"https://law.stanford.edu/press/irs-disproportionately-audits-black-taxpayers/\">study</a> that found the IRS disproportionately audits Black taxpayers, and about Ozempic, a shockingly effective – and expensive – weight loss drug.</p><p> </p><p>In the Plus segment: a debate over Slack etiquette.</p><p> </p><p>Podcast production by Anna Phillips.</p><p> </p>","author_name":"Slate Podcasts"}